Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
CVST-VITT in lage-, midden- en hoge-inkomenslanden
sep 2023 | Neuro-vasculair, Vaccinatie, Virale infecties